Suite 209 South — Chesterfield, Missouri

Suite 209 South is a clinical research site located in Chesterfield, Missouri, United States 63017.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Suite 209 South has participated in 1 clinical trials.

Therapeutic areas: Partial Epilepsy.

Sponsors: SK Life Science, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Suite 209 South?

Suite 209 South has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Suite 209 South conducted?

Suite 209 South has 1 clinical trials on record. Their work covers Partial Epilepsy.

Is Suite 209 South accredited by Crixeo Health?

Suite 209 South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Suite 209 South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.